We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$685M
2
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$54.5M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$42.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$27.7M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 11.47%
3 Healthcare 11.18%
4 Consumer Discretionary 10.98%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FET icon
2626
Forum Energy Technologies
FET
$932M
$95K ﹤0.01%
+5,087
New +$93.1K
GOCO
2627
DELISTED
GoHealth
GOCO
$95K ﹤0.01%
539
+454
+534% +$91.6K
IMAX icon
2628
IMAX
IMAX
$2.81B
$95K ﹤0.01%
4,723
-59
-1% -$1.18K
KALV
2629
DELISTED
KalVista Pharmaceuticals
KALV
$95K ﹤0.01%
3,684
+10
+0.3% +$263
PAHC icon
2630
Phibro Animal Health
PAHC
$1.37B
$95K ﹤0.01%
3,897
+3,126
+405% +$70.6K
PRTS icon
2631
CarParts.com
PRTS
$48.7M
$95K ﹤0.01%
670
-806
-55% -$130K
TILE icon
2632
Interface
TILE
$2.23B
$95K ﹤0.01%
7,620
+1,590
+26% +$18.9K
UMDD icon
2633
ProShares UltraPro MidCap400
UMDD
$35.8M
$95K ﹤0.01%
3,320
-16,940
-84% -$433K
VTGN icon
2634
VistaGen Therapeutics
VTGN
$11.6M
$95K ﹤0.01%
+1,486
New +$99.2K
PNTG icon
2635
Pennant Group
PNTG
$1.34B
$94K ﹤0.01%
2,056
+954
+87% +$52.5K
RVMD icon
2636
Revolution Medicines
RVMD
$44B
$94K ﹤0.01%
2,043
-1,820
-47% -$81.6K
FLXN
2637
DELISTED
Flexion Therapeutics, Inc.
FLXN
$94K ﹤0.01%
10,520
+9,099
+640% +$104K
ATER icon
2638
Aterian
ATER
$5.26M
$93K ﹤0.01%
262
+232
+773% +$89.4K
DAVA icon
2639
Endava
DAVA
$162M
$93K ﹤0.01%
+1,100
New +$91.9K
PLUS icon
2640
ePlus
PLUS
$2.32B
$93K ﹤0.01%
1,866
+990
+113% +$46.9K
RGNX icon
2641
Regenxbio
RGNX
$720M
$93K ﹤0.01%
2,745
+1,080
+65% +$46.1K
GRTS
2642
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$93K ﹤0.01%
9,787
+2,987
+44% +$41.1K
VBIV
2643
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$93K ﹤0.01%
995
-113
-10% -$11.5K
PRTY
2644
DELISTED
Party City Holdco Inc.
PRTY
$93K ﹤0.01%
16,041
-16,520
-51% -$120K
PROS
2645
DELISTED
ProSight Global, Inc.
PROS
$93K ﹤0.01%
7,388
+2,795
+61% +$35.5K
MTSC
2646
DELISTED
MTS Systems Corp
MTSC
$93K ﹤0.01%
1,598
-1,051
-40% -$61.6K
ALG icon
2647
Alamo Group
ALG
$2.01B
$92K ﹤0.01%
592
-405
-41% -$61.5K
HLIO icon
2648
Helios Technologies
HLIO
$2.66B
$92K ﹤0.01%
1,268
-113
-8% -$7.23K
IMVT icon
2649
Immunovant
IMVT
$8.8B
$92K ﹤0.01%
5,746
+3,296
+135% +$86.9K
LRN icon
2650
Stride
LRN
$3.27B
$92K ﹤0.01%
3,048
-12,441
-80% -$323K
104 105
106
107 108

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.